Aquestive Therapeutics (NASDAQ:AQST) 报告季度每股亏损$(0.19)，低于分析师普遍预期的$(0.14)，差距为35.71％。相比去年同期的每股亏损$(0.10)，这是一个90％的下降。公司报告季度销售额为$1187万，低于分析师普遍预期的$1308万，差距为9.30％。这一数据相较去年同期的销售额$1321万下降了10.14%。

以上内容来自Benzinga Earnings专栏，原文如下：

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.14) by 35.71 percent. This is a 90 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $11.87 million which missed the analyst consensus estimate of $13.08 million by 9.30 percent. This is a 10.14 percent decrease over sales of $13.21 million the same period last year.